Introduction
Interleukin 2 (IL-2) is a regulator of cell cycle progression in T lymphocytes, which binds to a speci®c cell surface receptor (Hatakeyama et al., 1989; Takeshita et al., 1992) . IL-2 withdrawal triggers an active cell death program in lymphokine-dependent cells (GoÂ mez et al., 1996 (GoÂ mez et al., , 1997 Broome et al, 1995a,b; Miyazaki et al., 1995) . The protein encoded by the bcl-2 gene is associated with suppression of apoptosis (Miyazaki et al., 1995; Wyllie, 1995; Weller et al., 1995; GoÂ mez et al., 1997) . Bcl-2 is located mainly in the outer membrane of mitochondria, as well as in the nuclear envelope and parts of the endoplasmic reticulum (Krajewski et al., 1993; De Jong et al., 1994) . Several signal transducing proteins have been reported to interact with Bcl-2, directly or indirectly, including the Ras-related protein p23 R-Ras (Fernandez-Sarabia and Bischo, 1993) , H-Ras (Chen and Faller, 1996) , the downstream eector protein kinase Raf-1 (Wang et al., 1996) and the phosphatase calcineurin (Shibasaki et al., 1997) .
The Ras protein superfamily comprises a large number of molecules involved in cell proliferation, dierentiation, cytoskeletal rearrangement, apoptosis, nuclear import of proteins and vesicular tracking (Ridley, 1995; Hall, 1998; Casey, 1995; James et al., 1994) . Ras proteins mediate IL-2-dependent cell survival (GoÂ mez et al., 1996; Izquierdo et al., 1995; Deng and Podack 1993) . Ras activation has been also linked to the promotion of cell death (reviewed in Downward, 1998) . Human cells contain four Ras protein homologues: H-Ras, N-Ras, K-Ras 4A and K-Ras 4. Selective activation of H-Ras by Ras-GRF has recently been reported, suggesting the potential participation of each Ras homologue in dierent signaling pathways (Jones and Jackson, 1998) . In addition, K-Ras, but not H-Ras has been described to speci®cally interact with microtubules (Thissen et al., 1997) .
Ras is post-transcriptionally modi®ed by prenylation at the C-terminal CAAX motif by a farnesyl protein transferase (FPT). After prenylation, the Cterminal tripeptide is removed by proteolysis and the newly exposed C-terminus is methylated. Ras prenylation is thought to facilitate membrane targeting and to be essential for Ras function (Kato et al., 1992) . In addition, this modi®cation can have important consequences for protein-protein interactions (Glomset and Farnsworth, 1994; Reis et al., 1991; James et al., 1995) . Prenylated H-Ras and NRas proteins can be further lipidated by palmitoylation. In contrast, K-Ras proteins are not palmitoylated, but possess a polybasic domain that can be reversibly phosphorylated (Glomset and Farnsworth, 1994, Egan et al., 1993) . Ras homologues also dier in their anity for FPT in vitro and in their sensitivity to FPT inhibition, since K-and N-Ras can be alternatively geranylgeranylated in cells treated with FPT inhibitors (Whyte et al., 1997; Lerner et al., 1997; Zhang et al., 1997) .
In this study, we have analysed the potential interactions between Bcl-2 and Ras proteins in a physiologically relevant model of T-lymphocyte apoptosis, and we have explored the dierential involvement of Ras homologues in these interactions.
Results

Ras interacts with Bcl-2 in TS1ab cells
Bcl-2 has been reported to interact with R-Ras in HL-60 cells, as well as with H-Ras in Jurkat cells overexpressing both H-Ras and Bcl-2. We have shown that exposure of the murine lymphokinedependent TS1ab cell line to IL-2 leads to Bcl-2 expression as well as to Ras activation, whereas IL-2 deprivation induces Ras activation, Bcl-2 downregulation and, consequently apoptosis (GoÂ mez et al., 1997 (GoÂ mez et al., , 1998 . To explore the potential interaction between Ras and Bcl-2 in TS1ab cells, we performed reciprocal co-immunoprecipitation experiments under normal growth conditions or after delivery of an apoptotic signal such as IL-2 deprivation. Ras was detected by Western blot in anti-Bcl-2 immunoprecipitates from total cell lysates of control IL-2-stimulated cells as well as of lymphokine-deprived cells (Figure 1a ). The amount of Ras detected in the Bcl-2 immunoprecipitates decreased with the length of the IL-2 deprivation period. This eect was probably due to the decrease in the amount of Bcl-2 protein that follows IL-2 deprivation, as evidenced by reprobing the membranes with anti-Bcl-2 antibody. In reciprocal experiments, Bcl-2 was detected by Western blot in anti-Ras immunoprecipitates from both IL-2-stimulated and -deprived cells. The amount of Bcl-2 detected decreased with the time of IL-2 deprivation. Ras protein levels did not diminish, however, as evidenced by reprobing the membranes with anti-Ras antibody. These results suggest that Ras interacts directly or indirectly with Bcl-2.
To identify the Ras proteins that may interact with Bcl-2, speci®c antibodies to H-, K-and N-Ras were used. Bcl-2 was detected in anti H-, K-and N-Ras immunoprecipitates from IL-2-stimulated or -deprived cells (Figure 1b) , suggesting that all three Ras proteins interact with Bcl-2. Lower Bcl-2 amounts were detected in the immunoprecipitates from IL-2-deprived cells, in accordance with the previously observed downregulation of Bcl-2 expression. In contrast, the amounts of the dierent Ras proteins did not decrease, as determined by reprobing the membranes with speci®c anti-Ras antibodies.
Ras proteins can be detected in mitochondria from TS1ab cells in association with Bcl-2
We tested whether Ras proteins could be detected in mitochondrial membrane. Western blot analysis of mitochondrial fractions of TS1ab cells with a panRas antibody revealed the presence of Ras proteins both in IL-2-supplemented and -deprived cells, although the levels detected were lower in the latter condition (Figure 2a ). Very small amounts of Ras proteins were visualized in the S100 fractions from these cells. The amount of Bcl-2 found in association with mitochondria from IL-2-deprived cells was also lower than under normal growth conditions, agreeing with the previously observed downregulation of Bcl-2 expression after IL-2 withdrawal (Gomez et al., 1997 (Gomez et al., , 1998 . As an internal control of mitochondria puri®cation, blots were probed with antibodies against tubulin (cytosolic 5610 6 ) were immunoprecipitated with anti-Bcl-2 antibody, transferred to nitrocellulose and immunoblotted with a pan-Ras antibody. The same blot was stripped and rehybridized with anti-Bcl-2 antibody. Similarly, lysates were immunoprecipitated with the pan-Ras antibody and immunoblotted with anti-Bcl-2 antibody. The blot was stripped and rehybridized with pan-Ras antibody. Protein bands were detected using the ECL system. Similar results were obtained in three independent experiments. An anti-IL-2 Ab was used as irrelevant antibody for immunoprecipitation. (b) A total of 30610 6 IL-2-stimulated or -deprived cells (8 h) were harvested, lysed, immunoprecipitated with anti-H-, K-or N-Ras antibodies and analysed by Western blot with anti-Bcl-2 antibody. The blot was stripped and rehybridized with the corresponding anti-H, K-or N-Ras antibodies. Protein bands were detected using the ECL Plus system. Similar results were obtained in two independent experiments. Molecular weight markers are indicated marker), protein-disulphide isomerase (PDI, marker of endoplasmic reticulum) and the IL-2 receptor subunit p55 (plasma membrane marker). Tubulin was detected in S100 fractions, but not in mitochondria of TS1ab cells, and only total TS1ab cell extracts showed PDI and p55 immunoreactivity. These observations suggest that mitochondrial preparations were not contaminated with other membrane fractions. To con®rm the association of Ras and Bcl-2, mitochondria were isolated from IL-2-stimulated or -deprived cells, lysed, immunoprecipitated with a pan-Ras antibody, and immunoblotted with anti-Bcl-2 ( Figure 2b ). Both proteins were coimmunoprecipitated after IL-2-stimulation or -deprivation.
K-, N-and H-Ras dierentially associate with mitochondria in IL-2-supplemented and -deprived cells
In order to identify the speci®c Ras proteins in mitochondria, mitochondrial and S100 fractions from TS1ab cells cultured in the presence or absence of IL-2 for 12 h were immunoblotted with speci®c antibodies to K-, N-and H-Ras (Figure 3 ). K-Ras was present in mitochondria from IL-2-supplemented cells, but could no longer be detected after 12 h of IL-2 deprivation. In contrast, H-Ras was detected in mitochondria only in IL-2-deprived cells. N-Ras protein was associated to mitochondria both in the presence and absence of IL-2, although the amount detected was lower in this latter situation. The S100 fractions of TS1ab did not contain detectable amounts of either of these Ras proteins when analysed by Western blot using speci®c anti-Ras antibodies (Figure 3 ), whereas the cellular debris pellets reacted with all three antibodies (not shown). Blots were reprobed with the anti-tubulin antibody as an internal control. Western blot analysis of total cell extracts showed that the levels of K-, N-and H-Ras did not change after IL-2 withdrawal in these experiments ( Figure 3a ). These results, together with the results shown in Figure 1b suggest that the changes in the amounts of mitochondria-associated Ras proteins are not the consequence of changes in the total amount of Ras, but of dierential targeting to mitochondria under IL-2 deprivation conditions. To explore the nature of this interaction, we assessed the presence of N-and H-Ras proteins in mitochondria after 24 h of IL-2 deprivation, a situation in which Bcl-2 is no longer detected ( Figure 1a ). Only traces of these proteins were detected in mitochondria from 24 h IL-2-deprived cells (Figure 3b) , suggesting that N-Ras is progressively lost from mitochondria of these cells and that H-Ras association with mitochondria is a transient phenomenon. In order to know whether the three Ras proteins are associated with Bcl-2 in mitochondria, reciprocal co-immunoprecipitations of Bcl-2 and each Ras homologue were done from the mitochondrial fraction. Results from Figure 3c show that Bcl-2 is associated with K-and N-Ras in IL-2-stimulated cells and with H-and N-Ras in IL-2-deprived cells.
Eect of Ras isoprenylation inhibitors on the mitochondrial association of Ras proteins
We next determined whether inhibition of Ras posttranslational modi®cations could aect association with mitochondria. The isoprenoid biosynthesis inhibitor mevastatin did not modify the pattern of Ras proteins associated with mitochondria, either in the absence or presence of IL-2 (Figure 4) . Similar results were obtained with the peptidomimetic Figure 2 Association of Ras and Bcl-2 in mitochondria. (a) Mitochondria and S100 fractions were isolated from 20610 6 IL-2-stimulated or -deprived cells (12 h). Proteins were separated in SDS ± PAGE, transferred to nitrocellulose and probed with panRas and anti-Bcl-2 antibody. As internal control of mitochondria puri®cation, blots were hybridized with anti-b tubulin isotype I+II, anti-PDI and anti-p55 IL-2 receptor antibodies. Total cell extracts were used as positive control for expression of PDI and p55 IL-2 receptor. Protein bands were detected using the ECL system. Similar results were obtained in two independent experiments. Molecular weight markers are indicated. (b) Mitochondria were isolated from 20610 6 and 30610 6 IL-2-stimulated or -deprived cells (8 h) respectively, lysed and immunoprecipitated with pan-Ras antibody. Proteins were probed with anti-Bcl-2 antibody. Blots were stripped and rehybridized with pan-Ras antibody. Protein bands were detected using the ECL Plus system. Similar results were obtained in two independent experiments. Molecular weight markers are shown inhibitor of FPT, B581 (James et al., 1993) . In cells treated with prenylation inhibitors, IL-2 deprivation appeared to induce a greater reduction in the amount of N-Ras associated to mitochondria. Using speci®c anti-K or anti-N-Ras antibodies, immunoblot analysis of S100 fractions from inhibitor-treated TS1ab cells did not allow the detection of cytosolic K-or N-Ras proteins. A small amount of H-Ras was observed in cytosol of IL-2-supplemented cells treated with the farnesyltransferase inhibitor B581. Reprobing of membranes with pan-Ras antibody showed Ras in the S100 fraction of mevastatin-treated cells, suggesting that the lack of detection by speci®c antibodies may be due to lower antibody anity performance.
Inhibition of Ras prenylation gives rise to the appearance of a slower migrating form of the protein in SDS gels, which corresponds to unfarnesylated Ras. To monitor the ecacy of the inhibitors used and to estimate the processing status of the mitochondriaassociated Ras proteins, we compared total cell Treatment with 20 mM mevastatin for 12 h partially inhibited Ras proteins processing, as indicated by the appearance of the unprocessed forms. Interestingly, the mitochondria-associated K-and N-Ras proteins comigrated with the processed forms, both in the presence and absence of mevastatin, although the levels detected were slightly lower in the presence of inhibitor. In contrast, H-Ras localized to mitochondria in IL-2-deprived cells was in the processed form in the absence of mevastatin, but coincided with the unfarnesylated form in mitochondria from mevastatintreated cells. These results evidence a distinct behavior for the dierent Ras proteins in their association with mitochondria.
Eect of Bcl-2 transfection on Ras proteins mitochondrial localization
In an attempt to discriminate between IL-2-and apoptosis-dependent phenomena, the mitochondrial localization of Ras proteins was studied after transient transfection of Bcl-2. Bcl-2 transfection eectively reduced the extent of apoptosis after IL-2 withdrawal (Figure 6a ). Western blot analysis of mitochondria isolated from Bcl-2-transfected and mock-transfected Figure 4 Eect of inhibitors of Ras post-translational processing on Ras protein localization. A total of 30610 6 IL-2-stimulated or -deprived cells were treated with 20 mM mevastatin or 100 mM FPT peptidomimetic inhibitor B581 for 12 h, after which mitochondria and S100 fractions were isolated. Aliquots containing 30 mg of protein were separated by SDS ± PAGE and immunoblotted with anti-K-, N-or H-Ras antibodies. The blot from mevastatin-treated cells was reprobed with pan-Ras antibody as internal control. Protein bands were detected using the ECL Plus system. Similar results were obtained in two independent experiments Figure 5 Eect of mevastatin on Ras protein processing in TS1ab cells. IL-2-stimulated or -deprived cells were treated with 20 mM mevastatin for 12 h, after which total cell extracts (E) and mitochondria (M) were isolated, separated by SDS ± PAGE, transferred to nitrocellulose and probed with anti-K-, N-or H-Ras antibodies. Protein bands were detected using the ECL Plus system. Similar results were obtained in three independent experiments. The two protein bands observed in mevastatin-treated cells are putatively identi®ed as the processed (p) or unprocessed (u) forms of Ras
Interaction of Ras and Bcl-2 in mitochondria
A Rebollo et al cells after 24 h of IL-2 deprivation showed that Bcl-2 overexpression brought about a partial of recovery KRas, and more evidently, of N-Ras associated with mitochondria in IL-2-deprived cells (Figure 6b ). On the other hand, Bcl-2 overexpression resulted in the mitochondrial association of H-Ras in a way apparently not dependent on IL-2 deprivation. This observation may be related to the exceedingly high levels of mitochondrial Bcl-2 attained in transfected cells cultured in the presence of IL-2 (Figure 6b , lower panel).
Eect of Ras isoprenylation inhibitors on the cell cycle distribution of TS1ab cells
Inhibition of isoprenoid biosynthesis with mevastatin induced apoptosis in IL-2 supplemented TS1ab cells, as evidenced by the appearance of cells with DNA content lower than G1 in¯ow cytometry analysis (Figure 7 ). Mevastatin also increased the proportion of sub-G1 cells under conditions of lymphokine-deprivation. Similar eects were observed in the case of FPT inhibitor B581. These results suggest that inhibition of Ras post-translational processing leads to apoptosis in IL-2-stimulated or deprived cells.
Discussion
The results presented here indicate that the antiapoptotic protein Bcl-2 can interact with the three Ras proteins TS1ab cells. This interaction may be direct or indirect, through a yet unidenti®ed protein or proteins. These observations extend the physiological importance of the previously reported interaction between Bcl-2 and Ras proteins (Chen and Faller, 1996) since, under our experimental conditions, there is no need for protein overexpression in order to observe this Interaction of Ras and Bcl-2 in mitochondria A Rebollo et al association. Ras upregulates Bcl-2 in several experimental systems (Wang et al., 1995; Fan and Bertino, 1997) , thus acting as a negative regulator of apoptosis. In turn, Bcl-2 has been reported to interact with the protein kinase Ras, one of the best characterized Ras eectors, in cells overexpressing both proteins (Wang et al., 1994) ; it also targets Ras to the mitochondria (Wang et al., 1996) . Although activated Ras proteins can mediate proliferative and antiapoptotic signals, under some circumstances, Ras can promote apoptosis and exert negative eects on the cell cycle (reviewed in Downward, 1998). K-Ras activation results in upregulation of both cell cycle stimulators and negative modulatory proteins (Fan and Bertino, 1997) . In TS1ab cells, activation of Ras proteins can occur either after IL-2 stimulation or deprivation (GoÂ mez et al., 1997) . The results presented here constitute, to the best of our knowledge, the ®rst biochemical study of the interaction between Bcl-2 and Ras homologues in a physiological model of apoptosis. K-, N-and H-Ras can be found in the mitochondrial fraction of TS1ab cells. The pattern of this association is strikingly dierent in IL-2-supplemented and in IL-2-deprived cells, however, with K-Ras present in mitochondria in detectable amounts only in IL-2-treated cells, and HRas associated with mitochondria only in IL-2-deprived cells. Since the total amount of the various Ras proteins did not change appreciably during IL-2 deprivation, the changes observed in the mitochondriaassociated protein levels probably re¯ect subcellular redistribution. These observations raise the question as to whether the interaction between Bcl-2 and Ras can also take place in other subcellular compartments. It is interesting to note that some Bcl-2-related proteins, such as Bax and Bcl-XL, undergo subcellular redistribution upon induction of apoptosis (Hsu et al., 1997) . For Bcl-2, extramitochondrial sites of action may exist (reviewed in Zamzami et al., 1998) . Our results suggest that Bcl-2 dierentially targets Ras members to the mitochondria. The observation that only traces of Ras proteins are detected in mitochondria after 24 h of IL-2 deprivation, when Bcl-2 protein levels are no longer detectable, further suggest that the presence of Bcl-2 is important for this association. This conclusion is also supported by the results of the Bcl-2 transfection experiment, in which increasing the levels of mitochondrial Bcl-2 was sucient to partially restore the mitochondrial association of N-Ras and, to a somewhat lesser extent, K-Ras. Alternatively, association of K-Ras with mitochondria in the absence of IL-2 may be an indirect eect of the antiapoptotic function of overexpressed Bcl-2. The meaning of the mitochondrial targeting of H-Ras under conditions of Bcl-2 overexpression in IL-2-stimulated cells is not clear at the moment, but it could be proposed that under conditions of unlimited mitochondrial Bcl-2 the constraints preventing H-Ras association are circumvented.
The post-translational modi®cation of Ras proteins by isoprenylation is required for targeting to the plasma membrane and interaction with protein acceptors and guanine nucleotide exchange factors and eectors (Siddiqui et al., 1998; Thissen et al., 1997) ; Okada et al., 1996) . To explore the importance of isoprenylation for Ras localization in TS1ab cells, we used both a speci®c FPT inhibitor as well as an inhibitor of isoprenoid biosynthesis. Treatment with these inhibitors did not substantially alter the pattern of dierential localization of Ras proteins to mitochondria, although the amounts of K-and N-Ras associated with mitochondria were lower in inhibitortreated cells. These eects were more pronounced in IL-2-deprived cells. These observations suggest that isoprenylation may be important for the interaction of these Ras homologues with the mitochondrial membrane and/ or proteins. In addition, when both processed and unprocessed forms of K-and N-Ras proteins were produced in cells by treatment with mevastatin, only the processed forms could be found in association with mitochondrial fractions. In contrast, the unprocessed form of H-Ras produced by mevastatin treatment, can also eectively associate with mitochondria in IL-2-deprived cells. This suggests that isoprenylation is not essential for mitochondrial targeting of H-Ras.
Inhibition of protein isoprenylation induces apoptosis in other experimental systems (PeÂ rez-Sala and Mollinedo, 1994) . In TS1ab cells, inhibition of both isoprenoid biosynthesis and of FPT induced apoptosis in the presence of IL-2. Treatment with these inhibitors resulted in a higher proportion of apoptotic cells under IL-2. Treatment with these inhibitors resulted in a higher proportion of apoptotic cells under IL-2 deprivation conditions. These eects cannot be attributed exclusively to inhibition of Ras processing, since both mevastatin and B581 target other cellular proteins.
The physiological role of the Ras and Bcl-2 association is not yet clear. The results reported here suggested that the IL-2-dependent subcellular redistribution of Ras proteins could be related to a dierential participation of the various Ras homologues in IL-2-dependent signaling processes. Dierent Ras proteins could be speci®cally targeted to mitochondria under growth-promoting or apoptotic conditions in TS1ab cells; each homologue being responsible for the activation of a dierent signaling cascade, leading to promotion or inhibition of cell death. The observations herein reported emphasize the importance of conducting homologue-speci®c studies when exploring the role of Ras proteins in cellular signaling.
Materials and methods
Cells and cultures
TS1ab is a IL-2-, IL-4-or IL-9-dependent mouse T cell line stably transfected with the a and b chains of human IL-2R (Pitton et al., 1993) . Cells were cultured in RPMI 1640 supplemented with 5% heat-inactivated fetal calf serum, 2 mM glutamine, 10 mM HEPES, 0.55 mM arginine, 0.24 mM asparagine, 50 mM 2-ME and 5 ng/ml rIL-2.
Lymphokines, antibodies and reagents
Human recombinant IL-2 was provided by Roussel Uclaf (Paris, France). Murine pan-Ras and anti-H-Ras, -K-Ras and -N-Ras antibodies were obtained from Oncogene Science (Cambridge, MA, USA), and murine anti-Bcl-2 mAb was from Transduction Laboratories (Lexington, KY, USA). Peroxidase (PO)-conjugated goat anti-rabbit or anti-mouse Ig antibodies were from Dako (Glostrup, Denmark). ECL and ECL Plus were obtained from Amersham (Buckinghamshire, UK), mevastatin and protease inhibitor cocktail were from Sigma (St. Louis, MO, USA), and B581 (FTase Inhibitor I) was from Calbiochem (La Jolla, CA, USA). Murine anti-PDI polyclonal antibody was provided by Dr Bonay (Centro de BiologõÂ a Molecular, Madrid, Spain). Antib tubulin isotype I+II antibody was from Sigma. Anti-p55 IL-2R and anti-IL-2 were from Pharmingen (San Diego, CA, USA). Capture-Tec pHook3 kit was from Invotrogene (San Diego, CA, USA). The construct encoding Bcl-2 was kindly provided by Dr Gabriel NuÂ n Ä ez.
Cell cycle analysis
A total of 2610 5 cells were washed and resuspended in PBS, permeabilized with 0.1% NP40 and stained with 50 mg/ml of propidium iodide (PI) immediately before analysis. Viable cells were analysed using an Epics XL¯ow cytometer (Coulter, Miami, FL, USA).
Transient transfection
Transfections were performed using the DEAE-dextran method as previously described (GoÂ mez et al., 1997 (GoÂ mez et al., , 1998 . Cells, from a mixed population of transfected and nontransfected cells, were isolated by binding to hapten coated magnetic beads. Mitochondria were isolated 24 h after transfection.
Immunoprecipitation and Western blot analysis
Cells (1610 7 ) were IL-2-stimulated or -deprived, then lysed for 20 min at 48C in lysis buer (50 mM Tris HCl pH 7.5, 1% NP40, 150 mM NaCl, 5 mM EDTA and protease inhibitor cocktail). Lysates were immunoprecipitated with the appropriate antibody. Protein-A Sepharose was added for 1 h at 48C and, after washing, immunoprecipitates were separated by SDS ± PAGE. Alternatively, cells (1610 6 ) were lysed in Laemmli sample buer and protein extracts separated by SDS ± PAGE, transferred to nitrocellulose and incubated with primary antibody. Membranes were washed and incubated with PO-conjugated second antibody and proteins were developed using the ECL or ECL Plus system. When stripping was required, membranes were incubated with 62.5 mM Tris-HCl pH 6.8, 2% SDS and 0.1 M 2-mercaptoethanol for 1 h at 658C and washed before reblocking and probing.
Isolation of mitochondria and S100 fractions Mitochondria were isolated using a modi®cation of a Yang et al. (1997) . Brie¯y, 20610 6 cells were IL-2-stimulated or -deprived, harvested and washed with ice-cold PBS. The cell pellet was suspended in 5 volumes of ice-cold buer A (20 mM HEPES-KOH pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF and 250 mM sucrose) supplemented with protease inhibitors. Cells were disrupted in a Dounce homogenizer, the nuclei centrifuged (1000 g, 10 min, 48C) and the supernatant further centrifuged (10 000 g, 15 min, 48C). The resulting mitochondrial pellet was resuspended in buer A and stored at 7808C. The supernatant was centrifuged (100 000 g, 1 h, 48C) and the resulting S100 fraction stored at 7808C.
